Double Blind Study Overview & Example

What is a Double-Blind Study?

A double-blind study is an experiment where the researchers and subjects don’t know who has been assigned to the treatment or control group. This experimental design deliberately hides treatment statuses from subjects and researchers to minimize biases that can occur when they know this information.

In the experimental design context, blinding refers to to procedures that hide treatment group assignments from those involved. While random assignment helps ensure initial group balance, it doesn’t prevent uneven treatment or assessment as the experiment proceeds, which could skew results.

So, what is the best way to sidestep potential biases?

Keep as many people in the dark about group assignments as possible.

Single, double, and triple-blinding indicates the number of groups that don’t know which participants are receiving the treatment. The three groups that can be blinded are participants, researchers, and data analysts. As mentioned above, a double-blinded study keeps the participants and researchers in the dark.

Generally, blinding more groups reduces bias and improves study validity. However, it’s not always possible to blind certain groups due to ethical or logistical constraints, which depend on the specifics of each study. Blinded designs vary based on who the project keeps unaware of treatment assignments.

While double-blind studies are common, alternative blinded designs exist to address specific research needs.

• Single-blinded study: Only the participants don’t know whether they receive the treatment.
• Triple-blinded study: The participants, researchers, and data analysts are all unaware of who received the real treatment or placebo.

Learn more about Experimental Designs: Definition and Types.

Why Use a Double-Blind Study?

Blinding helps improve a study’s internal validity, which is your degree of confidence that the treatment itself caused the improved experimental outcomes. In non-blinded studies, the knowledge of who is and is not receiving treatment can cause the three aforementioned groups to unknowingly change their behavior, observations, and analytical procedures. These changes introduce confounding variables that potentially explain the improved outcomes rather than the treatment. In your short, you are less confident that the treatment caused the improvements.

A double-blind study helps reduce sneaky biases that might creep into our experimental results.

• Confirmation Bias: Without double-blinding in an experiment, researchers might unconsciously favor results that align with their expectations. For example, they might interpret ambiguous data as positive effects of a new drug if they’re hopeful about its efficacy.
• Placebo Effect: Participants who know they’re getting the ‘real deal’ might report improved outcomes simply because they believe in the treatment’s power. Conversely, those aware they’re in the control group might not notice genuine improvements.
• Response Bias: Without double-blinding, participants might guess the study’s purpose or pick up on subtle cues from researchers, leading them to alter their responses to align with perceived expectations.
• Observer Bias: If a researcher knows which participant is in which group, they might inadvertently influence outcomes. Imagine a physiotherapist unknowingly encouraging a participant more because they know they’re receiving the new treatment.
• Demand Characteristics Bias: When the participants can guess the study’s goal, they might change their behaviors.

Let’s dig into how double-blind studies can help reduce the placebo effect and demand characteristics. We’ll look at a hypothetical non-blinded study of a new depression treatment. In this study, all groups know which participants are receiving the treatment.

Reducing the Placebo Effect Bias

In the non-blinded depression study, participants who know they are receiving the actual medication might report improved mood simply because they believe the treatment should work—this is the placebo effect. Their belief in the medication’s effectiveness can lead to perceived changes that are unrelated to the pill’s actual effects. The placebo effect makes it difficult to determine whether any improvements are due to the treatment itself or participants’ expectations.

A double-blind study design helps prevent these expectations from affecting outcomes because the participants don’t know whether they’re receiving a real treatment. These studies control for the placebo effect by giving control group participants a fake treatment that looks like the real treatment—a placebo, such as a sugar pill.

Learn more about the Placebo Effect Overview.

Reducing Demand Characteristics Bias

Demand characteristics can also influence the results of a non-blinded study. These are the subtle researcher behaviors and study details that influence subjects by suggesting researcher expectations about findings and how subjects should react to the treatment. They can also affect how researchers record the data.

In the non-blinded depression study, participants who know they are receiving the treatment might subconsciously alter their behavior to align with the researchers’ expectations, such as overstating improvements in mood. Similarly, researchers might inadvertently ask leading questions or record symptoms in a biased way for treatment group participants. For instance, they might interpret vague statements more favorably than they should. These distortions can skew the data and make it harder to measure the true impact of the treatment.

A double-blind study reduces these biases by hiding the group assignment from participants and the researchers who interact with them. To summarize, in a double-blind study:

• Subjects don’t know whether they’re receiving the treatment. Hence, their beliefs about it are less likely to affect the outcome.
• Researchers do not know who is receiving the treatment. Consequently, their expectations about the treatment are less likely to affect their interactions with the participants or how they assess and record outcomes.

Double-Blind Study Example

In a double-blind study on depression, researchers test the effectiveness of a new antidepressant. They recruit participants diagnosed with moderate depression and randomly assign them into two groups. One group receives the antidepressant, while the control group gets a placebo pill that looks identical to the real treatment.

Neither the participants nor the researchers know who receives the real drug. After eight weeks, researchers measure changes in depression symptoms using standardized questionnaires. The double-blind design helps prevent participants’ and researchers’ expectations from influencing the results.

Reference

Misra S. Randomized double blind placebo control studies, the “Gold Standard” in intervention based studies. Indian J Sex Transm Dis AIDS. 2012;33(2):131-4.